Response to Letter Regarding "Predictive Value of Preoperative Serum Albumin in Patients With Metastatic Spine Diseases: A Statistical Comment".

Autor: Cruz-Garza JG; Department of Neurosurgery, Houston Methodist Hospital, Houston, TX, USA., Hirase T; Department of Orthopedic and Sports Medicine, Houston Methodist Hospital, Houston, TX, USA., Bhenderu LS; Department of Neurosurgery, Houston Methodist Hospital, Houston, TX, USA., Taghlabi KM; Department of Neurosurgery, Houston Methodist Hospital, Houston, TX, USA., Faraji AH; Department of Neurosurgery, Houston Methodist Hospital, Houston, TX, USA., Marco RAW; Department of Orthopedic and Sports Medicine, Houston Methodist Hospital, Houston, TX, USA., Saifi C; Department of Orthopedic and Sports Medicine, Houston Methodist Hospital, Houston, TX, USA.
Jazyk: angličtina
Zdroj: Global spine journal [Global Spine J] 2024 Apr; Vol. 14 (3), pp. 1098-1099. Date of Electronic Publication: 2023 Apr 18.
DOI: 10.1177/21925682231172165
Abstrakt: We thank the authors for their interest in and commentary on "Preoperative Serum Albumin Level Predicts Length of Stay and Perioperative Adverse Events Following Vertebral Corpectomy and Posterior Stabilization for Metastatic Spine Disease." We appreciate the opportunity to respond to their comments herein.
Competing Interests: Declaration of conflicting interestsThe author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: Rex Marco has the following disclosures: DePuy, A Johnson & Johnson Company: Jesus Cruz-Garza, Takashi Hirase, Lokeshwar Bhenderu, Khaled Taghlabi, and Amir Faraji has no conflicts of interests to disclose. Paid presenter or speaker.Globus Medical: IP royalties. Comron Saifi has the following disclosures: Acquisition of Vertera Inc. by NuVasive’ Shares: Stock or stock Options. Alphatec Spine: Stock or stock Options. Nuvasive: Paid consultant. Restor3d: Stock or stock Options.
Databáze: MEDLINE
Externí odkaz: